Ideapharma Ltd

POWER SEARCH PRICING

SOLUTIONS

ideapharma ltd Company Information

Live

MatureSmallDeclining

Company Number

04121191

Next Accounts

Sep 2025

Industry

Management consultancy activities (other than financial management)

Directors

Eugene Krichevsky

Erik Nordhoy

Shareholders

michael rea

clare holly rea

View All

Group Structure

View All

Contact

Registered Address

the scalpel 18th floor, 52 lime street, london, EC3M 7AF

Website

www.ideapharma.com

ideapharma ltd Estimated Valuation

£3.3m

Pomanda estimates the enterprise value of IDEAPHARMA LTD at £3.3m based on Net Assets of £1.2m and 2.7x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Ideapharma Ltd is a live company located in london, EC3M 7AF with a Companies House number of 04121191. It operates in the management consultancy activities other than financial management sector, SIC Code 70229. Founded in December 2000, it's largest shareholder is michael rea with a 48.3% stake. Ideapharma Ltd is a mature, small sized company, Pomanda has estimated its turnover at £1.2m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Ideapharma Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 4 areas for improvement. Company Health Check FAQs

Health Rating3.5out of 5

5 Strong

2 Regular

4 Weak

Size

annual sales of £1.2m, make it larger than the average company (£536.8k)

Growth

3 year (CAGR) sales growth of -23%, show it is growing at a slower rate (8.3%)

EXPORT

Ideapharma Ltd's latest turnover from December 2023 is estimated at £1.2 million and the company has net assets of £1.2 million. According to their latest financial statements, Ideapharma Ltd has 23 employees and maintains cash reserves of £7.1 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Turnover	1,152,183	3,039,370	2,216,914	2,566,735	1,921,416	1,160,886	1,369,781	1,786,616	1,458,621	4,440,274	2,624,420	4,404,623	4,244,844	5,550,268	0
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	540,473	1,469,742	1,074,695	1,210,759	899,856	504,209	548,682	684,853	583,236	1,786,156	985,758	1,606,003	1,559,026	1,886,329	0
Gross Profit	611,709	1,569,628	1,142,220	1,355,976	1,021,560	656,677	821,099	1,101,763	875,384	2,654,117	1,638,662	2,798,620	2,685,819	3,663,940	0
Admin Expenses	875,528	1,598,301	964,609	1,202,807	484,408	284,269	501,302	1,138,236	1,029,268	2,633,677	1,451,515	2,799,368	2,567,825	3,591,578	135,473
Operating Profit	-263,819	-28,673	177,611	153,169	537,152	372,408	319,797	-36,473	-153,884	20,440	187,147	-748	117,994	72,362	-135,473
Interest Payable	59,976	42,059	19,798	9,150	5,044	7,472	4,551	3,690	1,625	0	0	0	0	0	0
Interest Receivable	568	2,978	643	244	650	874	475	27	55	13	13	12	10	6	2
Pre-Tax Profit	-323,227	-67,755	158,456	144,263	532,758	365,810	315,721	-40,137	-155,453	20,453	187,160	-736	118,004	72,368	-135,471
Tax	0	0	-30,107	-27,410	-101,224	-69,504	-59,987	0	0	-4,295	-43,047	0	-30,681	-20,263	0
Profit After Tax	-323,227	-67,755	128,349	116,853	431,534	296,306	255,734	-40,137	-155,453	16,158	144,113	-736	87,323	52,105	-135,471
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-323,227	-67,755	128,349	116,853	431,534	296,306	255,734	-40,137	-155,453	16,158	144,113	-736	87,323	52,105	-135,471
Employee Costs	1,156,667	966,731	815,424	579,982	641,669	649,427	592,148	828,905	849,607	1,800,953	1,074,674	1,874,460	1,751,124	2,309,610	0
Number Of Employees	23	20	17	13	13	12	12	15	15	31	19	32	31	43	0
EBITDA*	-193,157	55,206	255,339	193,618	566,644	397,257	345,895	-20,681	-146,042	28,682	197,727	27,112	144,035	95,517	-99,621

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Tangible Assets	33,524	58,107	51,665	23,346	18,416	10,843	5,916	11,004	12,515	12,713	12,083	14,635	44,000	48,641	65,028
Intangible Assets	19,857	61,768	79,135	94,748	64,337	11,313	30,864	40,846	0	0	0	0	0	0	1,795
Investments & Other	339,900	339,900	339,900	340,000	340,000	340,000	340,000	340,000	340,000	340,000	340,000	340,000	340,000	340,000	340,001
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	393,281	459,775	470,700	458,094	422,753	362,156	376,780	391,850	352,515	352,713	352,083	354,635	384,000	388,641	406,824
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	105,428	764,149	554,528	787,517	521,927	254,603	292,062	360,852	222,734	754,330	443,885	703,264	659,647	907,523	532,207
Group Debtors	974,365	903,992	799,220	379,084	467,835	630,550	400,397	0	94,231	0	0	0	0	0	0
Misc Debtors	560,821	615,134	390,233	189,036	250,499	184,582	183,618	206,687	139,690	0	88,448	56,399	53,770	0	0
Cash	7,053	14,592	155,556	358,598	128,693	44,709	188,426	1,616	19,620	2,570	2,500	2,605	2,391	1,629	933
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	1,647,667	2,297,867	1,899,537	1,714,235	1,368,954	1,114,444	1,064,503	569,155	476,275	756,900	534,833	762,268	715,808	909,152	533,140
total assets	2,040,948	2,757,642	2,370,237	2,172,329	1,791,707	1,476,600	1,441,283	961,005	828,790	1,109,613	886,916	1,116,903	1,099,808	1,297,793	939,964
Bank overdraft	224,314	72,767	91,858	0	0	149,455	71,946	68,090	0	0	0	0	0	0	0
Bank loan	41,667	100,000	100,000	43,750	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	57,644	302,777	198,987	74,727	59,169	56,904	162,528	80,992	108,647	556,219	349,680	723,780	705,949	928,947	598,223
Group/Directors Accounts	0	0	0	0	0	0	0	60,289	0	0	0	0	0	0	0
other short term finances	248,333	337,500	0	0	0	0	0	0	49,999	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	251,778	368,845	249,225	337,451	389,240	359,805	593,271	393,703	272,203	0	0	0	0	0	0
total current liabilities	823,736	1,181,889	640,070	455,928	448,409	566,164	827,745	603,074	430,849	556,219	349,680	723,780	705,949	928,947	598,223
loans	0	41,667	141,667	256,250	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	25,000
provisions	7,285	13,341	0	0	0	592	0	127	0	0	0	0	0	7,310	7,310
total long term liabilities	7,285	55,008	141,667	256,250	0	592	0	127	0	0	0	0	0	7,310	32,310
total liabilities	831,021	1,236,897	781,737	712,178	448,409	566,756	827,745	603,201	430,849	556,219	349,680	723,780	705,949	936,257	630,533
net assets	1,209,927	1,520,745	1,588,500	1,460,151	1,343,298	909,844	613,538	357,804	397,941	553,394	537,236	393,123	393,859	361,536	309,431
total shareholders funds	1,209,927	1,520,745	1,588,500	1,460,151	1,343,298	909,844	613,538	357,804	397,941	553,394	537,236	393,123	393,859	361,536	309,431

	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009
Operating Activities
Operating Profit	-263,819	-28,673	177,611	153,169	537,152	372,408	319,797	-36,473	-153,884	20,440	187,147	-748	117,994	72,362	-135,473
Depreciation	28,751	28,412	22,765	11,760	7,469	5,298	6,612	7,482	7,842	8,242	10,580	27,860	26,041	21,360	31,685
Amortisation	41,911	55,467	54,963	28,689	22,023	19,551	19,486	8,310	0	0	0	0	0	1,795	4,167
Tax	0	0	-30,107	-27,410	-101,224	-69,504	-59,987	0	0	-4,295	-43,047	0	-30,681	-20,263	0
Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Debtors	-642,661	539,294	388,344	115,376	170,526	193,658	308,538	110,884	-297,675	221,997	-227,330	46,246	-194,106	375,316	532,207
Creditors	-245,133	103,790	124,260	15,558	2,265	-105,624	81,536	-27,655	-447,572	206,539	-374,100	17,831	-222,998	330,724	598,223
Accruals and Deferred Income	-117,067	119,620	-88,226	-51,789	29,435	-233,466	199,568	121,500	272,203	0	0	0	0	0	0
Deferred Taxes & Provisions	-6,056	13,341	0	0	-592	592	-127	127	0	0	0	0	-7,310	0	7,310
Cash flow from operations	81,248	-247,337	-127,078	14,601	326,002	-204,403	258,347	-37,593	-23,736	8,929	7,910	-1,303	77,152	30,662	-26,295
Investing Activities
capital expenditure	-4,168	-72,954	-90,434	-75,790	-90,089	-10,225	-11,028	-55,127	-7,644	-8,872	-8,028	1,505	-21,400	-4,973	-102,675
Change in Investments	0	0	-100	0	0	0	0	0	0	0	0	0	0	-1	340,001
cash flow from investments	-4,168	-72,954	-90,334	-75,790	-90,089	-10,225	-11,028	-55,127	-7,644	-8,872	-8,028	1,505	-21,400	-4,972	-442,676
Financing Activities
Bank loans	-58,333	0	56,250	43,750	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	-60,289	60,289	0	0	0	0	0	0	0
Other Short Term Loans	-89,167	337,500	0	0	0	0	0	-49,999	49,999	0	0	0	0	0	0
Long term loans	-41,667	-100,000	-114,583	256,250	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	-25,000	25,000
share issue	12,409	0	0	0	1,920	0	0	0	0	0	0	0	-55,000	0	444,902
interest	-59,408	-39,081	-19,155	-8,906	-4,394	-6,598	-4,076	-3,663	-1,570	13	13	12	10	6	2
cash flow from financing	-236,166	198,419	-77,488	291,094	-2,474	-6,598	-64,365	6,627	48,429	13	13	12	-54,990	-24,994	469,904
cash and cash equivalents
cash	-7,539	-140,964	-203,042	229,905	83,984	-143,717	186,810	-18,004	17,050	70	-105	214	762	696	933
overdraft	151,547	-19,091	91,858	0	-149,455	77,509	3,856	68,090	0	0	0	0	0	0	0
change in cash	-159,086	-121,873	-294,900	229,905	233,439	-221,226	182,954	-86,094	17,050	70	-105	214	762	696	933

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for ideapharma ltd. Get real-time insights into ideapharma ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for ideapharma ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in EC3M area or any other competitors across 12 key performance metrics.

IDEAPHARMA LTD group structure

Ideapharma Ltd has 1 subsidiary company.

Ultimate parent company

IDEAPHARMA LTD

04121191

1 subsidiary

PROTODIGM LIMITED

04768451

IDEAPHARMA LTD Shareholders

michael rea	48.27%
clare holly rea	23.33%
jeremy stafford	12.77%
alexander wolfgang gray	5.43%
simon hersh	5.15%
ritacco rick	2.66%
james bohan	2.39%

Ideapharma Ltd currently has 2 directors. The longest serving directors include Mr Eugene Krichevsky (Nov 2024) and Mr Erik Nordhoy (Nov 2024).

officer	country	age	start	end	role
Mr Eugene Krichevsky	United States	49 years	Nov 2024	-	Director
Mr Erik Nordhoy	United States	60 years	Nov 2024	-	Director

P&L

December 2023

turnover

1.2m

-62%

operating profit

-263.8k

gross margin

53.1%

+2.8%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

1.2m

-0.2%

total assets

-0.26%

cash

7.1k

-0.52%

net assets

Total assets minus all liabilities

Similar Companies

two tees consultants ltd

1.5

advanced technology trading company ltd

azaria ltd

2.5

mph project development limited

mark chapman consulting limited

2.5

company number

04121191

Type

Private limited with Share Capital

industry

70229 - Management consultancy activities (other than financial management)

incorporation date

December 2000

ultimate parent company

None

previous names

N/A

address

the scalpel 18th floor, 52 lime street, london, EC3M 7AF

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to ideapharma ltd. Currently there are 0 open charges and 2 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for IDEAPHARMA LTD. This can take several minutes, an email will notify you when this has completed.

ideapharma ltd Company Information

ideapharma ltd Estimated Valuation

ideapharma ltd Estimated Valuation

ideapharma ltd Estimated Valuation

Ideapharma Ltd Overview

Ideapharma Ltd Health Check

IDEAPHARMA LTD financials

ideapharma ltd Credit Report and Business Information

Ideapharma Ltd Competitor Analysis

ideapharma ltd Ownership

ideapharma ltd directors

ideapharma ltd company details

ideapharma ltd Charges & Mortgages

ideapharma ltd Capital Raised & Share Issues BETA

ideapharma ltd Companies House Filings - See Documents